RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vitaspring Biomedical Co. Stock

Vitaspring Biomedical Co. Revenue 2024

Vitaspring Biomedical Co. Revenue

5.61 M USD

Ticker

VSBC

ISIN

US92851B1026

In 2024, Vitaspring Biomedical Co.'s sales reached 5.61 M USD, a 2,144% difference from the 250,000 USD sales recorded in the previous year.

The Vitaspring Biomedical Co. Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2022--
2021--
2020--
2019--
2018--
2017--

Vitaspring Biomedical Co. Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Vitaspring Biomedical Co., a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Vitaspring Biomedical Co. from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Vitaspring Biomedical Co.’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Vitaspring Biomedical Co.. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Vitaspring Biomedical Co.’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Vitaspring Biomedical Co.’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Vitaspring Biomedical Co.’s growth potential.

Vitaspring Biomedical Co. Revenue, EBIT and net profit per share

DateVitaspring Biomedical Co. RevenueVitaspring Biomedical Co. EBITVitaspring Biomedical Co. Net Income
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined

Vitaspring Biomedical Co. stock margins

The Vitaspring Biomedical Co. margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vitaspring Biomedical Co.. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vitaspring Biomedical Co..

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Vitaspring Biomedical Co.'s sales revenue. A higher gross margin percentage indicates that the Vitaspring Biomedical Co. retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Vitaspring Biomedical Co.'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Vitaspring Biomedical Co.'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the Vitaspring Biomedical Co.'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Vitaspring Biomedical Co.. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Vitaspring Biomedical Co.'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Vitaspring Biomedical Co. Margin History

Vitaspring Biomedical Co. Gross marginVitaspring Biomedical Co. Profit marginVitaspring Biomedical Co. EBIT marginVitaspring Biomedical Co. Profit margin
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %

Vitaspring Biomedical Co. Aktienanalyse

What does Vitaspring Biomedical Co. do?

Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Vitaspring Biomedical Co.'s Sales Figures

The sales figures of Vitaspring Biomedical Co. originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Vitaspring Biomedical Co.’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Vitaspring Biomedical Co.'s sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Vitaspring Biomedical Co.’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Vitaspring Biomedical Co. stock

How much revenue did Vitaspring Biomedical Co. generate this year?

Vitaspring Biomedical Co. has achieved a revenue of 5.61 M USD this year.

How much was the turnover of the company Vitaspring Biomedical Co. compared to the previous year?

The revenue of Vitaspring Biomedical Co. has increased by 2,144% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Vitaspring Biomedical Co.?

The revenue of Vitaspring Biomedical Co. is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Vitaspring Biomedical Co. measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Vitaspring Biomedical Co. so important for investors?

The revenue of Vitaspring Biomedical Co. is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Vitaspring Biomedical Co. pay?

Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of Vitaspring Biomedical Co.?

The current dividend yield of Vitaspring Biomedical Co. is .

When does Vitaspring Biomedical Co. pay dividends?

Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vitaspring Biomedical Co.?

Vitaspring Biomedical Co. paid dividends every year for the past 0 years.

What is the dividend of Vitaspring Biomedical Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vitaspring Biomedical Co. located?

Vitaspring Biomedical Co. is assigned to the '-' sector.

Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vitaspring Biomedical Co. from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Vitaspring Biomedical Co. pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Vitaspring Biomedical Co. in the year 2023?

In the year 2023, Vitaspring Biomedical Co. distributed 0 USD as dividends.

In which currency does Vitaspring Biomedical Co. pay out the dividend?

The dividends of Vitaspring Biomedical Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vitaspring Biomedical Co.

Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.